Sintx Technologies, Inc. (SINT)
USD 2.5
(-3.47%)
USD 2.5
(-3.47%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 15.2 Million USD | 16.05% |
| 2022 | 11.67 Million USD | 8.3% |
| 2021 | 10.77 Million USD | 9.2% |
| 2020 | 9.86 Million USD | 46.6% |
| 2019 | 6.73 Million USD | -12.28% |
| 2018 | 7.67 Million USD | -51.82% |
| 2017 | 15.92 Million USD | -30.7% |
| 2016 | 22.98 Million USD | -8.95% |
| 2015 | 25.24 Million USD | -35.31% |
| 2014 | 39.02 Million USD | 52.41% |
| 2013 | 25.6 Million USD | -15.83% |
| 2012 | 30.42 Million USD | -5.52% |
| 2011 | 32.19 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.24 Million USD | 18.63% |
| 2024 Q2 | 2.93 Million USD | -11.63% |
| 2023 Q4 | 2.73 Million USD | -32.68% |
| 2023 FY | 13.54 Million USD | 16.05% |
| 2023 Q1 | 3.67 Million USD | 18.75% |
| 2023 Q2 | 3.59 Million USD | -2.28% |
| 2023 Q3 | 4.05 Million USD | 12.88% |
| 2022 Q1 | 2.9 Million USD | 10.26% |
| 2022 Q2 | 2.79 Million USD | -3.58% |
| 2022 Q3 | 2.87 Million USD | 2.86% |
| 2022 Q4 | 3.09 Million USD | 7.68% |
| 2022 FY | 11.67 Million USD | 8.3% |
| 2021 Q3 | 2.87 Million USD | 20.2% |
| 2021 Q1 | 2.88 Million USD | 27.42% |
| 2021 Q2 | 2.39 Million USD | -17.01% |
| 2021 FY | 10.77 Million USD | 9.2% |
| 2021 Q4 | 2.63 Million USD | -8.46% |
| 2020 FY | 9.86 Million USD | 46.6% |
| 2020 Q1 | 1.89 Million USD | 11.08% |
| 2020 Q2 | 2.02 Million USD | 6.86% |
| 2020 Q3 | 2.44 Million USD | 20.54% |
| 2020 Q4 | 2.26 Million USD | -7.37% |
| 2019 Q2 | 1.55 Million USD | -10.98% |
| 2019 Q4 | 1.7 Million USD | -0.93% |
| 2019 FY | 6.73 Million USD | -12.28% |
| 2019 Q1 | 1.74 Million USD | 5.62% |
| 2019 Q3 | 1.72 Million USD | 10.67% |
| 2018 Q1 | 3.91 Million USD | 1.69% |
| 2018 FY | 7.67 Million USD | -51.82% |
| 2018 Q3 | 1.2 Million USD | -71.58% |
| 2018 Q4 | 1.65 Million USD | 37.57% |
| 2018 Q2 | 4.23 Million USD | 8.23% |
| 2017 Q1 | 3.77 Million USD | -36.03% |
| 2017 FY | 15.92 Million USD | -30.7% |
| 2017 Q4 | 3.84 Million USD | -6.29% |
| 2017 Q3 | 4.1 Million USD | -2.52% |
| 2017 Q2 | 4.21 Million USD | 11.67% |
| 2016 Q1 | 5.76 Million USD | -3.98% |
| 2016 FY | 22.98 Million USD | -8.95% |
| 2016 Q4 | 5.89 Million USD | 1.25% |
| 2016 Q2 | 5.5 Million USD | -4.46% |
| 2016 Q3 | 5.82 Million USD | 5.68% |
| 2015 FY | 25.24 Million USD | -35.31% |
| 2015 Q4 | 6 Million USD | 0.03% |
| 2015 Q3 | 6 Million USD | -0.2% |
| 2015 Q2 | 6.01 Million USD | -16.8% |
| 2015 Q1 | 7.22 Million USD | 15.12% |
| 2014 Q1 | 8.18 Million USD | 25.04% |
| 2014 FY | 39.02 Million USD | 52.41% |
| 2014 Q4 | 6.27 Million USD | -35.25% |
| 2014 Q3 | 9.69 Million USD | -34.76% |
| 2014 Q2 | 14.86 Million USD | 81.52% |
| 2013 Q1 | 6.08 Million USD | -28.72% |
| 2013 Q3 | 5.57 Million USD | -24.59% |
| 2013 Q4 | 6.54 Million USD | 17.36% |
| 2013 Q2 | 7.39 Million USD | 21.68% |
| 2013 FY | 25.6 Million USD | -15.83% |
| 2012 Q3 | 7.36 Million USD | 0.0% |
| 2012 FY | 30.42 Million USD | -5.52% |
| 2012 Q4 | 8.53 Million USD | 15.85% |
| 2011 FY | 32.19 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -35.433% |
| Cerus Corporation | 143.15 Million USD | 89.381% |
| OrthoPediatrics Corp. | 137.01 Million USD | 88.906% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -33.801% |
| Talis Biomedical Corporation | 67.18 Million USD | 77.375% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 39.064% |
| Inogen, Inc. | 236.08 Million USD | 93.561% |
| Spectral AI, Inc. | 20.86 Million USD | 27.142% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 72.854% |
| CVRx, Inc. | 76.14 Million USD | 80.036% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -330.868% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -21.715% |
| Orthofix Medical Inc. | 667.42 Million USD | 97.722% |
| Venus Concept Inc. | 80.47 Million USD | 81.111% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 73.133% |
| Bioventus Inc. | 409.91 Million USD | 96.292% |
| BrainsWay Ltd. | 28.01 Million USD | 45.746% |
| Envoy Medical, Inc. | 17.89 Million USD | 15.069% |
| electroCore, Inc. | 32.03 Million USD | 52.543% |
| IceCure Medical Ltd | 16.87 Million USD | 9.925% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 64.176% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 13.792% |
| MaxCyte, Inc. | 84.84 Million USD | 82.084% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -22.472% |
| Nexalin Technology, Inc. | 5.78 Million USD | -162.931% |
| PAVmed Inc | 64.82 Million USD | 76.551% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 70.24% |
| RxSight, Inc. | 103.85 Million USD | 85.363% |
| Sight Sciences, Inc. | 126.44 Million USD | 87.979% |
| SI-BONE, Inc. | 156.35 Million USD | 90.278% |
| TELA Bio, Inc. | 84.18 Million USD | 81.944% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 78.302% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 92.525% |
| LivaNova PLC | 843.54 Million USD | 98.198% |
| 908 Devices Inc. | 68.08 Million USD | 77.672% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 96.857% |
| Nemaura Medical Inc. | 7.13 Million USD | -112.935% |
| NeuroPace, Inc. | 75.29 Million USD | 79.812% |
| LENSAR, Inc. | 33.33 Million USD | 54.401% |
| Apyx Medical Corporation | 51.01 Million USD | 70.205% |
| Cutera, Inc. | 197.72 Million USD | 92.312% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 38.659% |
| BioSig Technologies, Inc. | 28.53 Million USD | 46.719% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 92.061% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 57.845% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 98.183% |
| Axonics, Inc. | 270.2 Million USD | 94.374% |
| Outset Medical, Inc. | 198.77 Million USD | 92.352% |
| IRIDEX Corporation | 31.81 Million USD | 52.219% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 91.565% |
| IRadimed Corporation | 30.12 Million USD | 49.537% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -78.165% |
| INVO Bioscience, Inc. | 7.85 Million USD | -93.562% |
| Telesis Bio, Inc. | 63.48 Million USD | 76.057% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 84.56% |
| Varex Imaging Corporation | 224.8 Million USD | 93.238% |
| Quipt Home Medical Corp. | 148.66 Million USD | 89.775% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -29.668% |
| Pulmonx Corporation | 112.68 Million USD | 86.51% |
| Dynatronics Corporation | 9.9 Million USD | -53.421% |
| Modular Medical, Inc. | 17.52 Million USD | 13.281% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 24.699% |
| Semler Scientific, Inc. | 38.94 Million USD | 60.967% |
| InMode Ltd. | 215.68 Million USD | 92.952% |
| Bruker Corporation | 1.07 Billion USD | 98.588% |
| Cytosorbents Corporation | 48.33 Million USD | 68.552% |
| DexCom, Inc. | 1.69 Billion USD | 99.101% |
| Align Technology, Inc. | 2.07 Billion USD | 99.268% |
| Viveve Medical, Inc. | 22.17 Million USD | 31.444% |
| ZimVie Inc. | 275.12 Million USD | 94.475% |
| Movano Inc. | 29.69 Million USD | 48.801% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 88.926% |
| Nexalin Technology, Inc. | 5.78 Million USD | -162.931% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -330.868% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 97.47% |
| Profound Medical Corp. | 33.6 Million USD | 54.763% |
| Insulet Corporation | 939.9 Million USD | 98.383% |
| enVVeno Medical Corporation | 25.23 Million USD | 39.769% |
| Surmodics, Inc. | 98.69 Million USD | 84.598% |
| iCAD, Inc. | 22.22 Million USD | 31.604% |
| Nuwellis, Inc. | 22.61 Million USD | 32.778% |
| Biotricity, Inc. | 17.18 Million USD | 11.543% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 96.591% |
| Aethlon Medical, Inc. | 12.27 Million USD | -23.812% |
| InspireMD, Inc. | 22.95 Million USD | 33.765% |
| PAVmed Inc. | 64.82 Million USD | 76.551% |
| BIOLASE, Inc. | 34.66 Million USD | 56.144% |
| Beyond Air, Inc. | 61.7 Million USD | 75.363% |
| FONAR Corporation | 28.6 Million USD | 46.858% |
| AxoGen, Inc. | 149.33 Million USD | 89.821% |
| Vivani Medical, Inc. | 26.96 Million USD | 43.627% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 91.416% |
| Inari Medical, Inc. | 448.59 Million USD | 96.611% |
| UFP Technologies, Inc. | 58.08 Million USD | 73.832% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -208.487% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -140.587% |
| Tenon Medical, Inc. | 16.96 Million USD | 10.414% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -105.613% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 65.533% |
| AdaptHealth Corp. | 1.07 Billion USD | 98.59% |
| NanoVibronix, Inc. | 4.97 Million USD | -205.671% |
| Quanterix Corporation | 118.1 Million USD | 87.129% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -29.668% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -5.256% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 96.129% |
| TransMedics Group, Inc. | 182.82 Million USD | 91.685% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 45.836% |
| NeuroMetrix, Inc. | 11.09 Million USD | -36.959% |
| Hyperfine, Inc. | 52.87 Million USD | 71.249% |
| Establishment Labs Holdings Inc. | 172 Million USD | 91.162% |
| Biomerica, Inc. | 6.97 Million USD | -117.842% |
| Bone Biologics Corporation | 9.42 Million USD | -61.227% |
| AVITA Medical, Inc. | 80.77 Million USD | 81.182% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -47.422% |
| Silk Road Medical, Inc | 186.35 Million USD | 91.843% |